Search

The article titled "[Retracted] Mammalian STE20-like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2-mediated mitophagy" has been retracted from the journal Molecular Medicine Reports. Concerns were raised by a reader regarding the similarity of certain images and data in the article to previously published work by different authors. The editor decided to retract the paper due to a lack of confidence in the presentation of the data and the authors' failure to provide an explanation. The retraction is regrettable and may cause inconvenience to readers. [Extracted from the article]

The article titled "[Retracted] SDF1/CXCR4 axis facilitates the angiogenesis via activating the PI3K/AKT pathway in degenerated discs" was published in Molecular Medicine Reports in 2020 but has since been retracted. Concerns were raised by a reader regarding the similarity of certain data in the article to data from other articles written by different authors at different research institutes. Additionally, duplicated data was found within the article. The editor of Molecular Medicine Reports decided to retract the paper due to these concerns. The authors were asked for an explanation but did not respond. [Extracted from the article]

The article titled "[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2" was published in Molecular Medicine Reports in 2021. However, it has since been retracted by the editor due to concerns raised by a reader. The reader pointed out that certain data in the article appeared to be similar to data from other papers under consideration for publication at the same time. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] Tumor suppressor miR-613 induces cisplatin sensitivity in non-small cell lung cancer cells by targeting GJA1," was published in Molecular Medicine Reports in 2021. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that certain data in the article, including colony formation assay data, tumor images, and migration assay data, were similar to data from other papers by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor has apologized for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Galectin-3 blockade suppresses the growth of cetuximab-resistant human oral squamous cell carcinoma" has been retracted from the journal Molecular Medicine Reports. A concerned reader brought to the editor's attention that the colony formation assay data in Figure 4C on page 6 were similar to data published in other articles by different authors at different research institutes. Since the contentious data had already been published before submission to the journal, the editor decided to retract the paper. The authors accepted the decision, and the editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway" was published in Molecular Medicine Reports in 2018 but has since been retracted. The retraction was prompted by a concerned reader who noticed similarities between the data presented in the article and data from other articles written by different authors at different research institutes. The editor of Molecular Medicine Reports decided to retract the paper, and the authors agreed with this decision. The retraction is an acknowledgment of the potential overlap in previously published data. [Extracted from the article]

The article titled "[Retracted] miR-218 functions as a tumor suppressor gene in cervical cancer" has been retracted from the journal Molecular Medicine Reports due to concerns about the validity of the data presented. A reader brought to the editor's attention that there were overlapping sections in the data panels, indicating that the results may not have been derived from separate experiments as intended. The authors were asked for an explanation but did not respond. The editor has retracted the paper due to a lack of confidence in the presented data. [Extracted from the article]

IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF- B pathways The Editor deeply regrets the grievance that this matter has caused to the authors of the previously published article, and also any inconvenience caused to the readership of the Journal. Mol Med Rep 9: 1834-1838, 2014; DOI: 10.3892/mmr.2014.2051 An interested reader of an article published in the journal I Circulation Research i [Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW and Kishore R: L-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. [Extracted from the article]

This document is a corrigendum published in the journal Molecular Medicine Reports. The authors of a previous paper on the treatment of rheumatoid arthritis with alcohol extracts from Anemone flaccida Fr. Schmidt have identified an error in Figure 4F of their study. The 'Control' data panel was mistakenly copied across for the '10 μg/ml' data panel. However, the correction of this error does not impact the results or conclusions of the study. The authors apologize for any inconvenience caused and express gratitude to the editor for allowing them to publish this corrigendum. [Extracted from the article]

This article, titled "[Retracted] miR-4306 inhibits the malignant behaviors of colorectal cancer by regulating lncRNA FoxD2-AS1," was published in Molecular Medicine Reports. However, it has since been retracted by the editor due to concerns raised by a reader. The reader pointed out that the colony formation assay data in Figure 5F were similar to data from other articles published before this one. Additionally, there were possible anomalies in the appearance of the western blots. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This document is a corrigendum for an article titled "Exosomal microRNA-4516, microRNA-203 and SFRP1 are potential biomarkers of acute myocardial infarction" published in Molecular Medicine Reports. The authors acknowledge that there were errors in Figure 1 of the original article, including the incorrect image being uploaded and the incorrect incorporation of the '+' and '-' signs for the 'Cell lysis' experiments. The revised version of Figure 1, which includes the correct image and labels, is provided in the corrigendum. The authors state that these errors did not significantly impact the results or conclusions of the paper. [Extracted from the article]

This document is a corrigendum for a paper published in the journal Molecular Medicine Reports. The authors acknowledge an error in Figure 2A of the original publication, where there was an unintentional duplication of an image and incorrect sample numbers. The revised version of Figure 2, which shows the correct data, is provided. The authors state that these errors did not significantly impact the results or conclusions of the paper. They emphasize the importance of a larger sample size for future studies and apologize for any inconvenience caused. The document also includes a graph and data on the expression levels of centromere protein M (CENPM) in various types of human cancer. [Extracted from the article]

This document is a corrigendum for an article published in Molecular Medicine Reports. The authors discovered errors in Figure 4 of their paper, where gel slices were mistakenly placed. The authors have corrected the data and provided the accurate version of Figure 4. They assure readers that these errors did not significantly impact the results or conclusions of the paper. The authors apologize for any inconvenience caused. The article discusses the association of FKBP11 expression levels with ER stress in IFN-γ/TNF-α-treated HT-29 cells. [Extracted from the article]

The article titled "[Retracted] Shengxian decoction decreases doxorubicin-induced cardiac apoptosis by regulating the TREM1/NF-κB signaling pathway" has been retracted from the journal Molecular Medicine Reports. A concerned reader brought to the editor's attention that the western blotting data in Figures 2D and 4C were similar to data published in other articles by different authors at different research institutes. Since the contentious data had already been published elsewhere before submission to the journal, the editor decided to retract the paper. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

[Corrigendum] Neuroprotective effect of emodin against Alzheimer's disease via Nrf2 signaling in U251 cells and APP/PS1 mice Mol Med Rep 23: 108, 2021; DOI: 10.3892/mmr.2020.11747 Subsequently to the publication of this paper, an interested reader drew to the authors' attention that the lower left panel of Fig. (A) Emodin decreased the escape latency time of APP/PS1 mice during the Morris water maze test. (B) Emodin decreased the time spent by APP/PS1 mice in the central area during the open field test. [Extracted from the article]

This article, titled "[Retracted] Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1," was published in Molecular Medicine Reports in 2013. However, it has since been retracted due to concerns raised by a reader. The reader pointed out similarities between the western blotting data in Figures 3D and 4A, as well as similarities between the protein bands in Figure 4C and data from other articles. The editor decided to retract the paper after the authors failed to provide a satisfactory explanation. The retraction notice apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "Effect of CCL2 siRNA on proliferation and apoptosis in the U251 human glioma cell line," was retracted from the journal Molecular Medicine Reports. A concerned reader brought to the editor's attention that the western blotting data shown in Figure 4A were similar to data from other articles written by different authors at different research institutes. Since the contentious data had already been published elsewhere before submission to the journal, the editor decided to retract the paper. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

3 in another article written by different authors at different research institutes [Liu Y, Li M, Zhang G and Pang Z: MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion. Mol Med Rep 14: 2511-2517, 2016; DOI: 10.3892/mmr.2016.5571 Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the cell invasion assay data shown for the "LSD1siRNA+DDP" experiment in Fig. [Extracted from the article]

5A and the cell migration and invasion assay data shown in Fig. Mol Med Rep 17: 3372-3379, 2018; DOI: 10.3892/mmr.2017.8264 Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the western blotting data shown in Fig. [Retracted] MicroRNA-675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin. [Extracted from the article]

[Retracted] Oxidized-low density lipoprotein accumulates cholesterol esters via the PKC -adipophilin-ACAT1 pathway in RAW264.7 cells 3 and 5 on p. 3604, contained apparent anomalies, including what appeared to be matching patternings of cellular data either within the same figure panels or comparing among the data panels. Mol Med Rep 12: 3599-3606, 2015; DOI: 10.3892/mmr.2015.3864 Following the publication of the above paper, a concerned reader drew to the Editor's attention that the "con" and "ox-LDL" panels in Fig. [Extracted from the article]

Furthermore, overlapping data panels were identified within this paper comparing the cell migration assay images between Figs. Mol Med Rep 16: 3606-3612, 2017; DOI: 10.3892/mmr.2017.6968 Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that various panels showing cell migration assay data in Figs. [Extracted from the article]

Mol Med Rep 22: 5145-5154, 2020; DOI: 10.3892/mmr.2020.11634 Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the GAPDH control western blotting data shown in Fig. [Retracted] Tripartite motif-containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway 1E in another article written by different authors at different research institutes [Liang T, Ye X, Liu Y, Qiu X, Li Z, Tian B and Yan D: FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of -catenin. [Extracted from the article]

Mol Med Rep 14: 1523-1530, 2016; DOI: 10.3892/mmr.2016.5401 Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the GAPDH control western blotting data shown in Fig. [Retracted] Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines Moreover, a pair of data panels showing the results from cell-cycle experiments purportedly performed under different experimental conditions in Fig. [Extracted from the article]

Mol Med Rep 17: 2113-2120, 2018; DOI: 10.3892/mmr.2017.8145 Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Hoechst staining data shown in Fig. [Retracted] Downregulation of miR-29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer 4E were strikingly similar to data appearing in different form in another article by different authors at a different research institute; moreover, an unexpectedly high degree of similarity was noted with the data featured in a couple of different data panels showing the results of apoptosis experiments in Fig. [Extracted from the article]

This document is a corrigendum published in the journal Molecular Medicine Reports. It addresses an error in a previously published paper titled "Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma." The error pertains to the Transwell cell migration and invasion assay data shown in Figure 6A and B for the 786-O cell line. The authors re-examined their original data and realized that the 'Invasion' panel in Figure 6B was chosen incorrectly. The revised version of Figure 6, featuring the correct data, is provided in the corrigendum. The authors state that this error did not affect the results or conclusions of the study. They apologize for any inconvenience caused. [Extracted from the article]

This document is a corrigendum for an article titled "Long non-coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR-522" published in Molecular Medicine Reports. The corrigendum addresses errors in the compilation of Figure 2, specifically in the data panels for cell invasion and migration assay experiments. The authors re-examined their original data and proposed a revised version of Figure 2. The errors did not significantly impact the results or conclusions of the paper. The authors apologize for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] A disintegrin and metallproteinase 15 knockout decreases migration of fibroblast-like synoviocytes and inflammation in rheumatoid arthritis," was published in Molecular Medicine Reports in 2015. However, it has since been retracted by the journal's editor due to concerns raised by a reader. The reader pointed out that certain data in the article appeared to be similar to data from other articles written by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to I Molecular Medicine Reports i , the Editor has decided that this paper should be retracted from the Journal. Mol Med Rep 18: 3099-3105, 2018; DOI: 10.3892/mmr.2018.9295 Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the data showing cell invasion assay experiments in Figs. [Extracted from the article]

Owing to the fact that the contentious data in the above article had already been published elsewhere prior to its submission to I Molecular Medicine Reports i , the Editor has decided that this paper should be retracted from the Journal. Mol Med Rep 18: 3106-3114, 2018; DOI: 10.3892/mmr.2018.9292 Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the data in the centre panel shown for the cell invasion assays in Fig. [Extracted from the article]

Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to I Molecular Medicine Reports i , the Editor has decided that this paper should be retracted from the Journal. Mol Med Rep 18: 2407-2416, 2018; DOI: 10.3892/mmr.2018.9186 Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the cell migration assay data shown in Fig. [Extracted from the article]

Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to I Molecular Medicine Reports i , the Editor has decided that this paper should be retracted from the Journal. Mol Med Rep 18: 1826-1834, 2018; DOI: 10.3892/mmr.2018.9106 Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the data shown in the cell invasion assays in Figs. [Extracted from the article]

Mol Med Rep 18: 1188-1196, 2018; DOI: 10.3892/mmr.2018.9069 Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the data shown for the cell migration and invasion assays in Figs. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to I Molecular Medicine Reports i , the Editor has decided that this paper should be retracted from the Journal. [Extracted from the article]

3 and 4, which showed apoptotic induction as evaluated by fluorescence microscopy and TEM evaluation of ferruginol-induced apoptosis in OVCAR-3 human ovary cancer cells, respectively. Mol Med Rep 16: 7013-7017, 2017; DOI: 10.3892/mmr.2017.7484 Following the publication of the above paper, an interested reader drew to our attention that a number of apparent anomalies existed with the data presented in a couple of the figures in the above paper. [Extracted from the article]

This article, titled "[Retracted] Salidroside mitigates hypoxia/reoxygenation injury by alleviating endoplasmic reticulum stress-induced apoptosis in H9c2 cardiomyocytes," was published in Molecular Medicine Reports in 2018. However, it has since been retracted by the editor due to concerns raised by a reader. The reader pointed out that certain data in the article were similar to data from another article written by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

The article titled "[Retracted] Tanshinone IIA regulates colorectal cancer apoptosis via attenuation of Parkin-mediated mitophagy by suppressing AMPK/Skp2 pathways" was retracted from the journal Molecular Medicine Reports. A concerned reader brought to the editor's attention that certain data in the article were similar to data already submitted for publication in another article by different authors at different research institutes. There were also concerns about the presentation of certain data. The authors were asked for an explanation but did not reply. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] Liraglutide protects renal mesangial cells against hyperglycemia-mediated mitochondrial apoptosis by activating the ERK-Yap signaling pathway and upregulating Sirt3 expression," was published in Molecular Medicine Reports in 2019. However, it has since been retracted due to concerns raised by a reader. The TUNEL assay data presented in Figures 1C and 5H were found to be similar to data published in other articles by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] SFRP2 modulates non-small cell lung cancer A549 cell apoptosis and metastasis by regulating mitochondrial fission via Wnt pathways," was published in Molecular Medicine Reports in 2019. However, it has since been retracted due to concerns raised by a reader. The reader pointed out that certain cellular images in the article were similar to data published in another article by different authors at different research institutes. The authors were asked for an explanation but did not provide a satisfactory reply. The editor has apologized for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] Protective effect of microRNA-381 against inflammatory damage of endothelial cells during coronary heart disease by targeting CXCR4," was published in Molecular Medicine Reports in 2020. However, it has since been retracted due to concerns about the cell proliferation assay data presented in Figure 4C. The data appeared to be strikingly similar to data from another article by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor has apologized for any inconvenience caused. [Extracted from the article]

THBS1 expression was reduced in the in vivo model mice injected with siTHBS1, as determined using (A) western blotting and (B) RT-qPCR (significance was found in parts B between the groups). Mol Med Rep 24: 869, 2021; DOI: 10.3892/mmr.2021.12509 Subsequently to the publication of this paper, the authors' noticed that the same -actin control bands were inadvertently used in the western blots shown in Figs. THBS1 expression was reduced in the in vitro primary myocardial cell cultures following siTHBS1 transfection, as determined using (C) western blotting and (D) RT-qPCR (significance was found in parts D between the groups). [Extracted from the article]

The authors confirm that there are no further errors in the study, and all the authors agree to this correction. Mol Med Rep 22: 3316-3326, 2020, DOI: 10.3892/mmr.2020.11392 Following the publication of this paper, the authors have realized that they overlooked indicating that Ting Liu and Jingjing Meng contributed equally to this work. [Extracted from the article]

Therefore, the revised version of the Funding section paragraph should read as follows: Funding The present study was supported by a grant from Poznan University of Medical Sciences (grant no. 502-14-02227367-10694). The authors confirm that there are no further errors in the study, and all the authors agree to this correction. Mol Med Rep 20: 4403-4414, 2019, DOI: 10.3892/mmr.2019.10709 Following the publication of this paper, the authors have requested that, on p. 4412 of the above article in the Funding section of the Declarations, the acknowledgement to one of the funding sources should be removed from the paper; essentially, the reference to grant no. 2018/31/B/NZ5/02475, formulated by the Polish National Science Centre (grant providing institution), should be removed from the paper. [Extracted from the article]

This article, titled "[Retracted] MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2," was published in Molecular Medicine Reports in 2014. However, it has since been retracted by the journal's editor due to concerns raised by a reader. The reader pointed out that the western blotting data and invasion assay data presented in the article were similar to data from other articles written by different authors at different research institutes. The authors were asked for an explanation but did not respond. The editor apologizes for any inconvenience caused. [Extracted from the article]

This article, titled "[Retracted] MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells," was published in the journal Molecular Medicine Reports in 2015. However, it has since been retracted due to concerns raised by a reader. The reader noticed that the data presented in Figure 3A and B of the article were very similar to data from other articles written by different authors at different research institutes. Some of these articles had already been published or were under consideration for publication at the same time. The authors were asked for an explanation but did not respond. The editor of the journal has apologized for any inconvenience caused. [Extracted from the article]

Mol Med Rep 12: 4843-4850, 2015; DOI: 10.3892/mmr.2015.4074 Following the publication of the above paper, a concerned reader drew to the Editor's attention that several figures (Figs. 8 in another paper published in I Molecular Medicine Reports i , which has now been retracted [Zhu Y-Y, Huang H-Y and Wu Y-L: Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells. [Extracted from the article]

Mol Med Rep 13: 4541-4548, 2016; DOI: 10.3892/mmr.2016.5105 Following the publication of the above paper, a concerned reader drew to the Editor's attention that several figures (Figs. 6 in another paper published in I Molecular Medicine Reports i , which has now been retracted [Zhu Y-Y, Huang H-Y and Wu Y-L: Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells. [Extracted from the article]